ReNAgade Therapeutics to Present at the Evercore ISI 2024 Emerging Biotech Conference
A webcast of the event will be available in the “News” section of the Company’s website at https://renagadetx.com/news/. A replay of the webcast will be archived on the Company’s website for 90 days following the presentation date.
About ReNAgade Therapeutics
ReNAgade exists to unlock the potential for RNA medicines to treat disease anywhere in the body. We combine our novel RNA delivery platforms with a comprehensive RNA platform allowing for an all-RNA system for coding, editing, and gene insertion to develop new medicines.
To accelerate the future of medicine, we bring together a team with deep RNA and delivery expertise to develop paradigm-shifting RNA medicines.
ReNAgade Therapeutics—RNA Without Limits
For more information about the company, its technologies, and its leadership, visit www.renagadetx.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240222038547/en/
Website: https://renagadetx.com/
Contact
ReNAgade Therapeutics
Investor Relations
Argot Partners
Emily Brabbit
(212) 600-1902
renagade@argotpartners.com
Media Relations
Argot Partners
Sarah Sutton
(212) 600-1902
renagade@argotpartners.com
This news is a press release provided by ReNAgade Therapeutics. Korea Newswire follows these editorial guidelines.
-
4월 28일 11:40